Download PDF
CC BY 4.0 · Journal of Health and Allied Sciences NU 2023; 13(04): 453-458
DOI: 10.1055/s-0042-1760090
Review Article

Impact of Vitamin D Level on Sarcopenia in Elderly People: A Critical Review

Saniya Khan
1   Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (deemed to be university), Wardha, Maharashtra, India
,
Sunil Kumar
1   Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (deemed to be university), Wardha, Maharashtra, India
,
Sourya Acharya
1   Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (deemed to be university), Wardha, Maharashtra, India
,
Anil Wanjari
1   Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (deemed to be university), Wardha, Maharashtra, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Vitamin D insufficiency is a widespread health issue globally, particularly among the elderly. Vitamin D controls and affects the metabolism and functionality of several human systems, including muscle tissue. The action of vitamin D on muscles has been extensively studied, with evidence indicating that this vitamin can increase the osteogenic differentiation of muscle fibers, hence preserving and enhancing muscular strength and athletic performance. Low hormone levels are more common in older people as a result of poor food intake and decreased skin ultraviolet irradiation. As a result, elderly persons who are deficient in vitamin D may be at risk of developing sarcopenia, a geriatric condition defined by gradual loss of skeletal muscle mass and strength that is frequently accompanied by adverse events such as falls, incapacity hospitalization, and mortality. As a result, these activities are seen to be crucial in illuminating the underlying functional condition of the aged, and functional mobility is employed as a technique for assessing fall risk and frailty. Several randomized controlled studies have been done to explore the efficacy of oral treatment in elderly people to prevent or cure sarcopenia; however, the results are still debatable. We describe the biochemical, clinical, and epidemiological data supporting the idea of a causal relationship between vitamin D insufficiency and a higher likelihood of sarcopenia in elderly adults in this narrative review. The muscular system, the biggest organ in the body, contributing to around 40% of body composition, is vital in exercising and glycogen depletion. Sarcopenia, a steady deterioration in muscle mass and strength, and function in the aged can result in prolonged circumstances, wheelchair confinement, and a reduction in quality of life. Diagnosis and control of muscle wasting are vital for improving health and quality of life in industrialized nations with aging populations. Vitamin D, a fat-soluble vitamin, has gained popularity in recent years because of its relevance in sarcopenia. The role of vitamin D deficiency and fortification on muscle wasting will be the focus of this review.

Keywords

vitamin D - sarcopenia - aging - quality of life


Publication History

Article published online:
20 January 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Remelli F, Vitali A, Zurlo A, Volpato S. Vitamin D deficiency and sarcopenia in older persons. Nutrients 2019; 11 (12) 2861
    CrossrefPubMedGoogle Scholar
  • 2 Panhwar YN, Naghdy F, Naghdy G, Stirling D, Potter J. Assessment of frailty: a survey of quantitative and clinical methods. BMC Biomed Eng 2019; 1 (01) 7
    CrossrefPubMedGoogle Scholar
  • 3 Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14 (02) 61-65
    PubMedGoogle Scholar
  • 4 Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 1989; 42 (08) 703-709
    CrossrefPubMedGoogle Scholar
  • 5 Lim S, Kim JH, Yoon JW. et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010; 33 (07) 1652-1654
    CrossrefPubMedGoogle Scholar
  • 6 Mori K. Maintenance of skeletal muscle to counteract sarcopenia in patients with advanced chronic kidney disease and especially those undergoing hemodialysis. Nutrients 2021; 13 (05) 1538
    CrossrefPubMedGoogle Scholar
  • 7 Yoon JH, Kwon KS. Receptor-mediated muscle homeostasis as a target for sarcopenia therapeutics. Endocrinol Metab (Seoul) 2021; 36 (03) 478-490
    CrossrefPubMedGoogle Scholar
  • 8 Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92 (06) 2017-2029
    CrossrefPubMedGoogle Scholar
  • 9 Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev 2008; 24 (06) 459-464
    CrossrefPubMedGoogle Scholar
  • 10 Houston DK, Nicklas BJ, Ding J. et al; Health ABC Study. Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr 2008; 87 (01) 150-155
    CrossrefPubMedGoogle Scholar
  • 11 Taofiq O, Fernandes A, Barros L, Barreiro MF, Ferreira IC. UV-irradiated mushrooms as a source of vitamin D2: a review. Trends Food Sci Technol 2017; 70: 82-94
    CrossrefGoogle Scholar
  • 12 Uchitomi R, Oyabu M, Kamei Y. Vitamin D and sarcopenia: potential of vitamin D supplementation in sarcopenia prevention and treatment. Nutrients 2020; 12 (10) 3189
    CrossrefPubMedGoogle Scholar
  • 13 Su Y, Hirayama K, Han TF, Izutsu M, Yuki M. Sarcopenia prevalence and risk factors among Japanese community dwelling older adults living in a snow-covered city according to EWGSOP2. J Clin Med 2019; 8 (03) 291
    CrossrefPubMedGoogle Scholar
  • 14 Kupisz-Urbańska M, Płudowski P, Marcinowska-Suchowierska E. Vitamin d deficiency in older patients—problems of sarcopenia, drug interactions, management in deficiency. Nutrients 2021; 13 (04) 1247
    CrossrefPubMedGoogle Scholar
  • 15 Minamino H, Katsushima M, Torii M. et al. Serum vitamin D status inversely associates with a prevalence of severe sarcopenia among female patients with rheumatoid arthritis. Sci Rep 2021; 11 (01) 20485
    CrossrefPubMedGoogle Scholar
  • 16 Granic A, Hill TR, Davies K. et al. Vitamin D status, muscle strength and physical performance decline in very old adults: a prospective study. Nutrients 2017; 9 (04) 379
    CrossrefPubMedGoogle Scholar
  • 17 Kim MK, Baek KH, Song KH. et al. Vitamin D deficiency is associated with sarcopenia in older Koreans, regardless of obesity: the Fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009. J Clin Endocrinol Metab 2011; 96 (10) 3250-3256
    CrossrefPubMedGoogle Scholar
  • 18 Bhurchandi S, Kumar S, Agrawal S. et al. Correlation of sarcopenia with modified frailty index as a predictor of outcome in critically ill elderly patients: a cross-sectional study. Cureus 2021; 13 (10) e19065
    PubMedGoogle Scholar
  • 19 Ganapathy A, Nieves JW. Nutrition and sarcopenia—what do we know?. Nutrients 2020; 12 (06) 1755
    CrossrefPubMedGoogle Scholar
  • 20 D'Amelio P, Quacquarelli L. Hypovitaminosis D and aging: is there a role in muscle and brain health?. Nutrients 2020; 12 (03) 628
    CrossrefPubMedGoogle Scholar
  • 21 Uusi-Rasi K, Patil R, Karinkanta S. et al. Exercise and vitamin D in fall prevention among older women: a randomized clinical trial. JAMA Intern Med 2015; 175 (05) 703-711
    CrossrefPubMedGoogle Scholar
  • 22 Cheng SH, Chen KH, Chen C, Chu WC, Kang YN. The optimal strategy of vitamin d for sarcopenia: a network meta-analysis of randomized controlled trials. Nutrients 2021; 13 (10) 3589
    CrossrefPubMedGoogle Scholar
  • 23 Lu Y, Niti M, Yap KB. et al. Effects of multi-domain lifestyle interventions on sarcopenia measures and blood biomarkers: secondary analysis of a randomized controlled trial of community-dwelling pre-frail and frail older adults. Aging (Albany NY) 2021; 13 (07) 9330-9347
    CrossrefPubMedGoogle Scholar
  • 24 McKendry J, Currier BS, Lim C, Mcleod JC, Thomas ACQ, Phillips SM. Nutritional supplements to support resistance exercise in countering the sarcopenia of aging. Nutrients 2020; 12 (07) 2057
    CrossrefPubMedGoogle Scholar
  • 25 Okuno J, Tomura S, Yabushita N. et al. Effects of serum 25-hydroxyvitamin D(3) levels on physical fitness in community-dwelling frail women. Arch Gerontol Geriatr 2010; 50 (02) 121-126
    CrossrefPubMedGoogle Scholar
  • 26 Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293 (18) 2257-2264
    CrossrefPubMedGoogle Scholar
  • 27 Rejnmark L. Effects of vitamin d on muscle function and performance: a review of evidence from randomized controlled trials. Ther Adv Chronic Dis 2011; 2 (01) 25-37
    CrossrefPubMedGoogle Scholar
  • 28 Dominguez LJ, Farruggia M, Veronese N, Barbagallo M. Vitamin D sources, metabolism, and deficiency: available compounds and guidelines for its treatment. Metabolites 2021; 11 (04) 255
    CrossrefPubMedGoogle Scholar
  • 29 Zhang L, Quan M, Cao ZB. Effect of vitamin D supplementation on upper and lower limb muscle strength and muscle power in athletes: a meta-analysis. PLoS One 2019; 14 (04) e0215826
    CrossrefPubMedGoogle Scholar
  • 30 Greising SM, Baltgalvis KA, Lowe DA, Warren GL. Hormone therapy and skeletal muscle strength: a meta-analysis. J Gerontol A Biol Sci Med Sci 2009; 64 (10) 1071-1081
    CrossrefPubMedGoogle Scholar